The Francis Crick Institute, a leading biomedical research centre in London, has become the latest organisation to join CaSE.
The Francis Crick Institute joins CaSE
08 Oct 2019
Commenting on the announcement, Executive Director, Dr Sarah Main said:
“Since its formation in 2015, The Francis Crick Institute has played a vital role in pushing the boundaries of biomedical discovery and bolstering the international reputation of UK science. We are therefore delighted that the Crick has chosen to join CaSE’s expanding and diverse membership of research institutes, universities, learned societies and businesses.
We look forward to harnessing the Crick’s authority and expertise, allowing us to make the strongest possible case to Government for the funding, skills and policies to unlock the full potential of UK science and innovation.”
Gemma Wood, Head of External Affairs at the Francis Crick Institute:
“The Crick brings together outstanding scientists from all disciplines, carrying out research that will help improve the health and quality of people’s lives, and keep the UK at the forefront of medical innovation.
“Science and engineering are essential to our future, and CaSE does important work highlighting the benefits that the sector brings to society. Their evidence-based approach to a broad range of policy areas is valuable, and we look forward to working with them to engage on the critical issues facing the sector.”
About the Francis Crick Institute
The Francis Crick Institute is dedicated to understanding the fundamental biology underlying health and disease. Our work is helping to understand why disease develops and to translate discoveries into new ways to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections and neurodegenerative diseases.
An independent organisation, our founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL, Imperial College London and King’s College London.
The Crick was formed in 2015, and in 2016 we moved into our brand new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe.
Related press
The Campaign for Science and Engineering (CaSE) is delighted to welcome the Cell and Gene Therapy (CGT) Catapult into its membership.
The Campaign for Science and Engineering (CaSE) is thrilled to welcome UCB into its membership.
CaSE is pleased to welcome Elsevier into its membership. Elsevier have supported CaSE’s work for many years, and we are delighted they have joined us as members.
Alicia Greated will be the new Executive Director of the Campaign for Science and Engineering (CaSE) from early April 2024.